IGF1 and prostate carcinoma: Lawrence et al. (2003) [56], found that IGF-I could potentially contribute to the immortalization process of malignancy by up-regulating telomerase activation, leading to telomere lengthening and extension of the cellular life span of prostate cancer cells [56].